CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive loss	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jun. 30, 2021			94,504
Beginning balance at Jun. 30, 2021	$ 2,529,590	$ (216,066)	$ 2	$ 2,777,155	$ (245,066)	$ (100)	$ (247,467)	$ 29,000
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			1,033
Issuance of common stock upon exercise of stock options and release of restricted stock units	8,644			8,644
Issuance of common stock under the employee stock purchase plan (in shares)			40
Issuance of common stock under the employee stock purchase plan	5,726			5,726
Issuance of common stock upon public offering, net of underwriting discounts and other offering costs (in shares)			5,074
Issuance of common stock upon public offering, net of underwriting discounts and other offering costs	1,341,122			1,341,122
Issuance of common stock as consideration for an acquisition (in shares)			1,788
Issuance of common stock as consideration for an acquisition, net of issuance costs	488,263			488,263
Fair value of replacement awards	26,710			26,710
Purchase of capped calls	(37,893)			(37,893)
Stock-based compensation	38,839			38,839
Other comprehensive income (loss)	(39)					(39)
Net loss	(74,259)						(74,259)
Ending balance (in shares) at Sep. 30, 2021			102,439
Ending balance at Sep. 30, 2021	4,110,637		$ 2	4,403,500		(139)	(292,726)
Beginning balance (in shares) at Jun. 30, 2021			94,504
Beginning balance at Jun. 30, 2021	2,529,590	$ (216,066)	$ 2	2,777,155	$ (245,066)	(100)	(247,467)	$ 29,000
Net loss	(241,419)
Ending balance (in shares) at Mar. 31, 2022			104,183
Ending balance at Mar. 31, 2022	4,068,316		$ 2	4,535,699		(7,499)	(459,886)
Beginning balance (in shares) at Sep. 30, 2021			102,439
Beginning balance at Sep. 30, 2021	4,110,637		$ 2	4,403,500		(139)	(292,726)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			1,022
Issuance of common stock upon exercise of stock options and release of restricted stock units	14,140			14,140
Stock-based compensation	50,701			50,701
Other comprehensive income (loss)	(1,711)					(1,711)
Net loss	(80,440)						(80,440)
Ending balance (in shares) at Dec. 31, 2021			103,461
Ending balance at Dec. 31, 2021	4,093,327		$ 2	4,468,341		(1,850)	(373,166)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			680
Issuance of common stock upon exercise of stock options and release of restricted stock units	6,332			6,332
Issuance of common stock under the employee stock purchase plan (in shares)			42
Issuance of common stock under the employee stock purchase plan	7,123			7,123
Stock-based compensation	53,903			53,903
Other comprehensive income (loss)	(5,649)					(5,649)
Net loss	(86,720)						(86,720)
Ending balance (in shares) at Mar. 31, 2022			104,183
Ending balance at Mar. 31, 2022	4,068,316		$ 2	4,535,699		(7,499)	(459,886)
Beginning balance (in shares) at Jun. 30, 2022			104,731
Beginning balance at Jun. 30, 2022	4,043,694		$ 2	4,598,737		(10,217)	(544,828)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			835
Issuance of common stock upon exercise of stock options and release of restricted stock units	3,901			3,901
Issuance of common stock under the employee stock purchase plan (in shares)			67
Issuance of common stock under the employee stock purchase plan	8,494			8,494
Stock-based compensation	73,352			73,352
Other comprehensive income (loss)	(270)					(270)
Net loss	(81,640)						(81,640)
Ending balance (in shares) at Sep. 30, 2022			105,633
Ending balance at Sep. 30, 2022	4,047,531		$ 2	4,684,484		(10,487)	(626,468)
Beginning balance (in shares) at Jun. 30, 2022			104,731
Beginning balance at Jun. 30, 2022	4,043,694		$ 2	4,598,737		(10,217)	(544,828)
Net loss	(207,854)
Ending balance (in shares) at Mar. 31, 2023			106,688
Ending balance at Mar. 31, 2023	4,104,337		$ 2	4,887,200		(3,183)	(779,682)
Beginning balance (in shares) at Sep. 30, 2022			105,633
Beginning balance at Sep. 30, 2022	4,047,531		$ 2	4,684,484		(10,487)	(626,468)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			663
Issuance of common stock upon exercise of stock options and release of restricted stock units	4,316			4,316
Issuance of common stock as consideration for an acquisition (in shares)			40
Issuance of common stock as consideration for an acquisition, net of issuance costs	3,376			3,376
Stock-based compensation	119,604			119,604
Other comprehensive income (loss)	4,126					4,126
Net loss	(95,076)						(95,076)
Ending balance (in shares) at Dec. 31, 2022			106,336
Ending balance at Dec. 31, 2022	4,083,877		$ 2	4,811,780		(6,361)	(721,544)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			596
Issuance of common stock upon exercise of stock options and release of restricted stock units	2,643			2,643
Issuance of common stock under the employee stock purchase plan (in shares)			115
Issuance of common stock under the employee stock purchase plan	$ 9,385			9,385
Repurchase and retirement of common stock (in shares)	(359)
Repurchase and retirement of common stock	$ (27,000)
Stock-based compensation	63,392			63,392
Other comprehensive income (loss)	3,178					3,178
Net loss	(31,138)						(31,138)
Ending balance (in shares) at Mar. 31, 2023			106,688
Ending balance at Mar. 31, 2023	$ 4,104,337		$ 2	$ 4,887,200		$ (3,183)	$ (779,682)